US approves Israeli treatment for Buerger’s disease

Israel biotech Pluristem has received orphan drug status from the US Food and Drugs Administration for its stem cell treatment of blood vessels disease.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.